Your 0.25mg dose requires only 5 units on the syringe
At the median, spending on food at home decreased by $10/week and spending on food away from home (e.g., restaurants) decreased by $30/week compared to pre-medication food spending
Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments
These insights support more informed conversations with your provider about whether sweetener optimization, medication trials, or combination approaches align with your genetic landscape